Summary
Yifang Ma is an investment leader with 11 years of experience focused on healthcare and biotech investing, currently serving as Investment Associate Director at SIIC Capital. Previously as Investment Director at HosenCare Brothers she led deal sourcing, diligence, valuation and negotiations for 10+ investments and drove multiple successful exits, including IPOs and share transfers. Her background combines hands-on financial modeling and commercial due diligence from roles at CDH Investments and earlier investment banking and legal stints supporting high-profile IPOs. Trained in law (Peking University) with a B.Sc. in traditional medicine and a master’s in European studies, she brings a rare cross-disciplinary view that bridges clinical science, regulatory nuance and transaction law. Based in Hong Kong, she prefers direct, business-first outreach and operates with a pragmatic, deal-oriented style.
11 years of coding experience
6 years of employment as a software developer
Juris Doctor & Chinese Juris Master, Law, Juris Doctor & Chinese Juris Master, Law at Peking University
理学学士学位, B.Sc., 理学学士学位, B.Sc. at Beijing University of Chinese Medicine
Master in European Studies, Master in European Studies at Sapienza Università di Roma